Skip to content

ADMA Biologics ADMA Interest Expense

Interest Expense at other companies

Zymeworks logo
ZymeworksZYME
$2.71M-20.8%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$12.3M+2.5%
Quest Diagnostics logo
Quest DiagnosticsDGX
-$63M+6.0%
TG Therapeutics logo
TG TherapeuticsTGTX
$7.67M+13.5%
Abbott logo
AbbottABT
$174M+32.8%
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Revenue$114.5M-0.3%
Gross profit$80.8M+32.2%
Operating income$58.3M+67.1%
Net income$45.3M+68.5%
EPS (diluted)$0.19+72.7%

Balance sheet

See full
Cash & equivalents$138.2M+92.9%
Total debt$204.4M+2,055%
Total equity$390.3M+4.5%
Total assets$665.2M+30.3%

Cash flow

See full
Operating cash flow$58.2M+396%
CapEx$2.5M-45.9%
Free cash flow$55.7M+329%

Valuation

See full
Market cap$2.01B-54.5%
Enterprise value$2.08B-52.5%
P/E12.2×-9.2×
P/S-5.7×

Profitability

See full
Gross margin61.3%+8.7pp
Operating margin42.1%+9.0pp
Net margin32.4%-12.6pp
FCF margin21.2%+1.4pp

Returns & leverage

See full
Return on equity43.3%-35.2pp
Debt / equity0.5×+0.5×
Current ratio+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ADMA Biologics's interest expense?
ADMA Biologics (ADMA) reported interest expense of $2.1M in Q1 2026.
How has ADMA Biologics's interest expense changed year-over-year?
ADMA Biologics's interest expense increased by 6.3% year-over-year, from $1.98M to $2.1M.
What is the long-term trend for ADMA Biologics's interest expense?
Over 4 years (2021 to 2025), ADMA Biologics's interest expense has grown at a -14.1% compound annual growth rate (CAGR), from $13.06M to $7.11M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.